355 related articles for article (PubMed ID: 26297978)
21. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis.
Bohan A; Chen WS; Denson LA; Held MA; Boyer JL
J Biol Chem; 2003 Sep; 278(38):36688-98. PubMed ID: 12837754
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury.
Yu L; Liu X; Li X; Yuan Z; Yang H; Zhang L; Jiang Z
Toxicol Lett; 2016 Dec; 264():1-11. PubMed ID: 27818225
[TBL] [Abstract][Full Text] [Related]
23. Protective Effects of Alisol B 23-Acetate Via Farnesoid X Receptor-Mediated Regulation of Transporters and Enzymes in Estrogen-Induced Cholestatic Liver Injury in Mice.
Meng Q; Chen X; Wang C; Liu Q; Sun H; Sun P; Huo X; Liu Z; Yao J; Liu K
Pharm Res; 2015 Nov; 32(11):3688-98. PubMed ID: 26040663
[TBL] [Abstract][Full Text] [Related]
24. Oral administration of oleanolic acid, isolated from Swertia mussotii Franch, attenuates liver injury, inflammation, and cholestasis in bile duct-ligated rats.
Chai J; Du X; Chen S; Feng X; Cheng Y; Zhang L; Gao Y; Li S; He X; Wang R; Zhou X; Yang Y; Luo W; Chen W
Int J Clin Exp Med; 2015; 8(2):1691-702. PubMed ID: 25932098
[TBL] [Abstract][Full Text] [Related]
25. Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.
Weerachayaphorn J; Mennone A; Soroka CJ; Harry K; Hagey LR; Kensler TW; Boyer JL
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G925-36. PubMed ID: 22345550
[TBL] [Abstract][Full Text] [Related]
26. Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.
Denk GU; Soroka CJ; Takeyama Y; Chen WS; Schuetz JD; Boyer JL
J Hepatol; 2004 Apr; 40(4):585-91. PubMed ID: 15030973
[TBL] [Abstract][Full Text] [Related]
27. Oleanolic acid alters bile acid metabolism and produces cholestatic liver injury in mice.
Liu J; Lu YF; Zhang Y; Wu KC; Fan F; Klaassen CD
Toxicol Appl Pharmacol; 2013 Nov; 272(3):816-24. PubMed ID: 23948738
[TBL] [Abstract][Full Text] [Related]
28. AMP-activated protein kinase-farnesoid X receptor pathway contributes to oleanolic acid-induced liver injury.
Huang J; Liao S; Fu X; Wang Y; Zhou S; Lu Y
J Appl Toxicol; 2023 Aug; 43(8):1201-1213. PubMed ID: 36846903
[TBL] [Abstract][Full Text] [Related]
29. Farnesoid X receptor contributes to oleanolic acid-induced cholestatic liver injury in mice.
Feng H; Hu Y; Zhou S; Lu Y
J Appl Toxicol; 2022 Aug; 42(8):1323-1336. PubMed ID: 35128688
[TBL] [Abstract][Full Text] [Related]
30. Picroside II alleviates liver injury induced by alpha-naphthylisothiocyanate through AMPK-FXR pathway.
Li T; Zheng R; Xu L; Zhou M; Wang X; Guo Q; Ji H; Li L
Toxicol Appl Pharmacol; 2020 Dec; 408():115248. PubMed ID: 32976922
[TBL] [Abstract][Full Text] [Related]
31. Yangonin protects against estrogen-induced cholestasis in a farnesoid X receptor-dependent manner.
Dong R; Wang J; Gao X; Wang C; Liu K; Wu J; Liu Z; Sun H; Ma X; Meng Q
Eur J Pharmacol; 2019 Aug; 857():172461. PubMed ID: 31220436
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
Boyer JL; Trauner M; Mennone A; Soroka CJ; Cai SY; Moustafa T; Zollner G; Lee JY; Ballatori N
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1124-30. PubMed ID: 16423920
[TBL] [Abstract][Full Text] [Related]
34. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems.
Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Sugimoto H; Utsunomiya H; Oda K; Warabi E; Ishii T; Yamamoto M
Biochem Biophys Res Commun; 2009 Nov; 389(3):431-6. PubMed ID: 19732748
[TBL] [Abstract][Full Text] [Related]
35. Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.
Soroka CJ; Mennone A; Hagey LR; Ballatori N; Boyer JL
Hepatology; 2010 Jan; 51(1):181-90. PubMed ID: 19902485
[TBL] [Abstract][Full Text] [Related]
36. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter.
Renga B; Migliorati M; Mencarelli A; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
Biochim Biophys Acta; 2011 Mar; 1809(3):157-65. PubMed ID: 21296199
[TBL] [Abstract][Full Text] [Related]
37. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
[TBL] [Abstract][Full Text] [Related]
38. Minimal role of hepatic transporters in the hepatoprotection against LCA-induced intrahepatic cholestasis.
Beilke LD; Besselsen DG; Cheng Q; Kulkarni S; Slitt AL; Cherrington NJ
Toxicol Sci; 2008 Mar; 102(1):196-204. PubMed ID: 18032408
[TBL] [Abstract][Full Text] [Related]
39. Targeting FXR in cholestasis: hype or hope.
Fiorucci S; Distrutti E; Ricci P; Giuliano V; Donini A; Baldelli F
Expert Opin Ther Targets; 2014 Dec; 18(12):1449-59. PubMed ID: 25200104
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis.
Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ
Drug Metab Dispos; 2007 Mar; 35(3):402-9. PubMed ID: 17151194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
